Overview

Overview

Cmed Medical Services offers comprehensive and dynamic support to Cmed’s Clinical Services CRO, including:

  • Medical and scientific input to clinical study protocols or synopses.
  • Medical and safety monitoring of clinical studies.
  • Medical writing support.
  • Support to Cmed’s Consultancy Services.

Experience is the difference

Our seasoned medical staff have extensive experience in the pharmaceutical and CRO industry, including:

  • All phases of drug development (TM, I-IV) – strongest in early phase and first-in-human to Phase II POC clinical studies.
  • Multiple therapy areas, especially oncology and rare diseases, immune-inflammation, respiratory, gastrointestinal and CNS disorders.
  • Studies involving a wide variety of compounds including: small molecular entities (NCEs), biopharmaceuticals (monoclonal antibodies, antibody fragments, antibody drug conjugates and immune check point inhibitors), vaccines, cell therapy (including CAR-T cells),gene therapy products and medical devices.
  • This group is supported by a network of KOLs, established relationship with investigative sites and scientific advisors who can provide guidance on a project-by-project basis.

Want to learn more?

Please feel free to contact us if you would like to learn more about our skills and experience. We are friendly, open and here to help.

Contact us